Stockscreener 앱 받기
199.08
1.31%
-2.64
시간 외 거래:
199.08
Icon Plc 주식(ICLR)의 최신 뉴스
Precision neuropsychiatry spotlight: a BioCentury podcast - BioCentury
ICON discovers over £10,000 of energy savings following audit by Green Zone Surveys - The Energyst
ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations - Yahoo Finance
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies - sharewise
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call - sharewise
ICON plc to Announce 2024 Financial Results in February 2025 - TipRanks
Clinical Research Giant ICON Announces Critical Q4 Results Timeline - StockTitan
TD Cowen cuts ICON stock price target to $254, maintains Buy rating - MSN
Contract Clinical Research Organization Market Set to Witness Significant Growth by 2025-2032:ICON plc, - EIN News
Europe Pharmacovigilance and Drug Safety Software Market Forecast, Regional Share and Growth Opportunity Analysis to 2031 - GlobeNewswire Inc.
ICON Public (ICLR) Stock Price, News & Analysis - MarketBeat
Arkadios Wealth Advisors Lowers Stock Holdings in ICON Public Limited (NASDAQ:ICLR) - Defense World
Healthcare Contract Research Outsourcing Market Projected To Witness Substantial Growth, 2025-2032: ICON plc, - EIN News
eClinical Solutions Market Key Players AnalysisIcon Plc, - openPR
RBC Capital Initiates Coverage of ICON Public Limited (ICLR) with Outperform Recommendation - MSN
Icon (ICLR) 3-Year EPS without NRI Growth Rate : 8.70% (As of Sep. 2024) - GuruFocus.com
Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates - MSN
Icon sees FY25 adjusted EPS $13.00-$15.00, consensus $14.93 - Yahoo Finance
Icon PLC (ICLR) Stock Price Down 6.6% on Jan 14 - GuruFocus.com
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty - Benzinga
ICON plc stock retains Overweight rating amid conservative growth forecasts - Investing.com India
ICON plc stock retains Overweight rating amid conservative growth forecasts By Investing.com - Investing.com Australia
ICON Issues Financial Guidance for Full Year 2025 - sharewise
ICON plc Announces 2025 Financial Guidance Amid Market Challenges - TipRanks
Decentralized Clinical Trials Market Recent Growth: Market - openPR
ICON Public (NASDAQ:ICLR) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World
ICON Survey: 97% Use Biomarkers in Neurodegenerative Trials, But Innovation Gaps Persist - StockTitan
ICON's SWOT analysis: CRO giant faces headwinds amid long-term growth potential - Investing.com India
ICON plc draws bullish views at RBC on attractive valuation - MSN
Icon PLC (ICLR) Stock Price Up 4.66% on Jan 7 - GuruFocus.com
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
ICON plc to Present at the J.P. Morgan Healthcare Conference - TipRanks
Why Icon Plc Shares Face Rocky Times Ahead - TipRanks
ICON Properties Plc (ICON.mw) Q42024 Interim Report - AfricanFinancials
ICON Clinches TIME Magazine's Top CRO Ranking, Dominates Industry Awards in 2024 - StockTitan
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research - Silicon Canals
ICON appoints Barry Balfe as COO - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Shareholders to Inquire about Securities Investigation - AccessWire
Bioanalytical Services Market Key Players AnalysisPPD, Inc., - openPR
ICON plc appoints Barry Balfe as new COO By Investing.com - Investing.com Australia
ICON plc Appoints Barry Balfe as Chief Operating Officer - TipRanks
ICON plc appoints Barry Balfe as new COO - Investing.com
ICON Appoints 20-Year Veteran Barry Balfe as Chief Operating Officer to Drive Strategic Growth - StockTitan
Truist cuts ICON price target to reflect company commentary - Investing.com
ICON's SWOT analysis: CRO giant navigates turbulent market - Investing.com
October 2025 Options Now Available For Icon - Nasdaq
Contract Research Organization Services Market Set to Witness Significant Growth by 2024-2031: IQVIA, LabCorp, - EIN News
0.69%
0.37%
자본화:
|
볼륨(24시간):